Myxovirus Replication in Chicken Embryos Can Be Suppressed by
SUMMARY Injection of the protease, inhibitor, aprotinin, into the allantoic cavity of embryonated eggs infected at low m.o.i, with different influenza viruses and paramyxoviruses markedly reduced multiplication by at least 100-fold. Under these conditions, most viral particles produced were non-infectious and contained uncleaved glycoproteins, presumably resulting from aprotinin suppression of protease activity.
The myxoviruses (influenza viruses and paramyxoviruses), like other enveloped viruses, contain glycoproteins which are located outside the virion lipid bilayer as 'spikes'. The spike glycoproteins, HA of influenza viruses and F of paramyxoviruses, undergo post-translational proteolytic cleavage. This cleavage is a precondition for the fusion activity of these glycoproteins, and thus for the infectivity of the virions (Klenk et al., 1975; Lazarowitz & Choppin, 1975; Ohuchi & Homma, 1976; Scheid & Choppin, 1974) . Glycoproteins synthesized as precursor proteins Fo and HA (mol. wt. 75 x 103 to 65 × 103) are cleaved to yield two disulphide-linked subunits F1, F2, HA1 and HA2 with mol. wt. of 60 x 103 to 50 x 103 and 25 x 103 to 15 x 103, respectively (Scheid & Choppin, 1977; Skehel & Waterfield, 1975; Lambert & Pons, 1983) . A 82 x 103 mol. wt. precursor (HNo) of the second paramyxovirus spike glycoprotein HN (mol. wt. 74 x 103) has also been identified (Nagai et al., 1976; Nagai & Klenk, 1977) .
The cleavage of these viral glycoproteins is accomplished by host proteases which are present in cells (Klenk et al., 1975; Scheid & Choppin, 1976; Silver et al., 1978; Rott et al., 1980) and in extracellular fluids, e.g. serum, allantoic or amniotic fluids (Lazarowitz et al., 1973; Muramatsu & Homma, 1980; Zhirnov et al., 1982c; Appleyard & Davis, 1983) . The activation of myxoviruses specifically requires trypsin-like proteases for cleavage of F0 and HA (Klenk et al., 1975; Lazarowitz & Choppin, 1975; Scheid & Choppin, 1976; Nagai & Klenk, 1977) whereas the activation of HNo to HN + 8K could be performed by proteases of various specificities (Nagai & Klenk, 1977) .
It has long been known that chicken embryos are a permissive host for most influenza viruses and paramyxoviruses (Burnet, 1936) . This permissiveness is in part due to the presence of trypsin-like proteases both in the chorioallantoic membrane cells (Klenk et al., 1975; Rott et al., 1980) and in the allantoic and amniotic fluids of chicken embryos (Muramatsu & Homma, 1980; Zhirnov et al., 1982c; Appleyard & Davis, 1983) which cleave the viral glycoproteins to permit virus multicycle replication (Klenk et al., 1975; Scheid & Choppin, 1976; Nagai et al., 1979) . In this report, we have used the protease inhibitor aprotinin to inhibit proteases capable of the activation of virus infectivity. Aprotinin is a polypeptide of approx, mol. wt. 6000 obtained from animal organs and is an inhibitor of a wide range of proteases such as trypsin, chymotrypsin, kallikrein, plasmin and cathepsin (Trautschold et al., 1967) . This anti-protease agent is widely used in medical practice to prevent bleeding, hyperfibrinolysis, and i n the treatment of pancreatitis (D6m6t6r, 1975; Malis et al., 1979; Miiller et al., 1980; Freidenberg et al., 1981) . The officinal aprotinin compounds in this work [Gordox® (Gedeon Richter, Hungary) and Contrycal® (GERMED, G.D.R.)] did not cause a visible toxic effect and did not change the normal development of chicken embryos (results not shown). After incubation, samples of allantoic fluids were taken for haemagglutinin titrations (using 1% chicken red blood cells), infectivity assay and polypeptide analysis (see Fig.  1 ). The infectivity of the sample was determined by plaque assay on primary cultures of chicken embryo cells. The modified plaque assay employed consisted of a double agar overlay, with trypsin included in the second layer added 24 h (WSN, Udorn, La Sota, Queensland) or 48 h (Sendai) after infection. In the standard method, trypsin was included in the agar from the beginning. The exact experimental details are as described (Zhirnov et al., 1982a) .
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The infectivity of orthomyxoviruses influenza A/WSN (H 1 N 1) and A/Udorn/72 (H3N2), and paramyxoviruses Sendai and Newcastle disease (NDV; La Sota and Queensland) grown in aprotinin-treated chicken embryos was measured by two plaque assay methods. The modified method allows the determination of the real infectivity of the virus population, i.e. virions with cleaved glycoproteins, whereas the potential infectivity, i.e. that provided by the combined effect of virions with cleaved and uncleaved glycoproteins is measured by the standard method (Zhirnov et al., 1982a, c; Appleyard & Davis, 1983) . The results of a typical experiment are shown in Table 1 . It can be seen that the virus produced by control embryos (not treated with aprotinin) had the highest infectivity. However, the real infectivity of the virus produced by aprotinin-treated embryos was significantly (102-fold and more) lower. The most prominent reduction (more than 103-fold) of progeny virus infectivity was observed in aprotinin-treated embryos infected with NDV Queensland. The overall virus yield was also found to be markedly reduced by aprotinin in the chicken embryos infected with all virus strains examined (Table 1 ; standard method). Virus yield was decreased further with increases in aprotinin concentration and there was little multiplication at doses of 5 x 103 to 10 x 103 units of aprotinin per embryo (not shown).
In Fig. 1 , an analysis of polypeptides of the viruses produced in the control and aprotinintreated embryos is shown. The viruses grown in the allantoic cavity of control embryos contained glycoproteins in a cleaved form: HA1 + HA2 in influenza viruses or F1 + F2 and HN in paramyxovirus strains (Fig. 1, lanes 1) . When grown in chicken embryos treated with aprotinin, the WSN and Udorn influenza A viruses predominantly contained uncleaved IP: 54.70.40.11
On: Thu, 20 Dec 2018 21:20:03 Gordox (lane 7) . The large cleavage fragment FI of NDV strains stained poorly and was scarcely seen in whole virus, but was clearly identified in the soluble fraction when the virus was treated with non-ionic detergent (not shown). The small paramyxovirus fragment F2 co-migrated with the buffer front and was not visible in the gel.
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ta~ Short communication haemagglutinin (HA) and Sendai and La Sota paramyxoviruses had uncleaved fusion glycoprotein F0 (Fig. 1, lanes 3 to 5) . It can also be seen that both glycoproteins of the NDV Queensland synthesized in aprotinin-treated embryos are present in uncleaved forms, F0 and HNo (Fig. 1, lanes 6, 7) . The latter observation correlates with the infectivity assay which indicates a minimal proteolytic activation of the Queensland virus strain in aprotinin-treated embryonated eggs. The data presented here demonstrated that multicycle replication both of influenza viruses and of paramyxoviruses in chicken embryos could be effectively suppressed by a physiological protease inhibitor, aprotinin. The antiviral activity of aprotinin was shown to be realized through the blockage of viral glycoprotein cleavage and prevention of virus activation. Even a single injection of aprotinin into the allantoic cavity of the infected embryonated eggs inhibited proteolytic activation and markedly reduced virus multicycle replication (see Table 1 ). The almost complete inhibition of virus replication in the chicken embryos could be maintained by daily aprotinin injections (not shown). We have also noted that virus suppression by aprotinin depends on the virus strain itself. This strain-specific susceptibility of virus to aprotinin is most probably determined by the degree of inhibition of viral glycoprotein cleavage in the drugtreated embryos. The data presented here are in good agreement with previous studies demonstrating the ability of protease inhibitors to prevent the proteolytic activation of myxoviruses in vitro (Lazarowitz et al., 1973; Appleyard & Davis, 1983) , in cultured cells (Zhirnov et al., 1982c; Dubovi et al., 1983) , organ culture (Tashiro & Homma, 1983) , and influenza-infected animals (Zhirnov et al., 1984a) .
The proteolytic activation of virus glycoprotein resulting in the formation of highly infectious virions has been shown to be a key factor in the spreading of infection and the pathogenic action in the host organism for both influenza viruses (Bosch et al., 1979 (Bosch et al., , 1981 Nakajima & Sugiura, 1980; Rott et al., 1980; Vallbracht et al., 1980) and paramyxoviruses (Nagai et al., 1976 (Nagai et al., , 1979 Garten et al., 1980; Madansky & Bratt, 1981) . Our results reported here demonstrated that virus proteolytic activation could be controlled to reduce the development of a multicycle infection. This approach could be valuable because many human viruses, such as measles virus (Fujinami & Oldstone, 1981) , respiratory syncytial virus (Dubovi et al., 1983; Lambert & Pons, 1983) , human parainfluenza viruses (Shimokata et al., 1980; Shibuta et al., 1982) , mumps virus (Merz & Wolinsky, 1981 ; Merz et al., 1983) , and influenza A, B and C viruses (Lazarowitz & Choppin, 1975; Klenk et al., 1975; Sugawara et al., 1981) require proteolytic events for their activation and virulence. Previously, we have described that influenza virus proteolytic activation can be suppressed by protease inhibitors (Zhirnov et al., 1982c (Zhirnov et al., , 1984a ) and a therapeutic effect in influenza-infected animals has been found (Zhirnov et al., 1982b) . Clinical trials during an outbreak of influenza H3N2 virus in February to April 1983 also demonstrated the antiviral and therapeutic efficacy of aerosol inhalations of anti-protease compounds (Zhirnov et al., 1984b) . The present studies have shown that the multiplication of paramyxoviruses is similarly inhibited by aprotinin and therefore that the proposed chemotherapeutic approach may also be feasible for paramyxovirus-induced infections (for review, see Zhirnov, 1983) .
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